Associated Papers
SLCO1B1 and SLC10A1 polymorphism and plasma rifampin concentrations in patients with co-morbidity tuberculosis-diabetes mellitus in Baja California, Mexico.
Perea-Jacobo R et al.
Tuberculosis (edinburgh, Scotland), 2022
Structural Plasticity Is a Feature of Rheostat Positions in the Human Na+/Taurocholate Cotransporting Polypeptide (NTCP).
Ruggiero MJ et al.
International Journal of Molecular Sciences, 2022
35328632 (PubMed )
Supplement: ijms-23-03211-s001.zip › ijms-1601123-supplementary.pdf
Variant discovery using next-generation sequencing and its future role in pharmacogenetics.
Russell LE et al.
Pharmacogenomics, 2020
Homozygous p.Ser267Phe in SLC10A1 is associated with a new type of hypercholanemia and implications for personalized medicine.
Liu R et al.
Scientific Reports, 2017
28835676 (PubMed )
Supplement: 41598_2017_7012_MOESM1_ESM.doc
More Power to OATP1B1: An Evaluation of Sample Size in Pharmacogenetic Studies Using a Rosuvastatin PBPK Model for Intestinal, Hepatic, and Renal Transporter-Mediated Clearances.
Emami Riedmaier A et al.
Journal of Clinical Pharmacology, 2016
Interindividual variability in hepatic organic anion-transporting polypeptides and P-glycoprotein (ABCB1) protein expression: quantification by liquid chromatography tandem mass spectroscopy and influence of genotype, age, and sex.
Prasad B et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2014
Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects.
Fahrmayr C et al.
Drug Metabolism Reviews, 2010
Select a paper to view details